Search Results 271-280 of 1735 for 搜索引擎yandex咨询邮箱：lgooxc@hotmail.com

  1. A Phase III, Safety, Tolerability and Efficacy of Combination Treatment of BL-8040 and G-GSF as Compared to Placebo and G-CSF for thE MobilizatioN of HematopoiEtic Stem Cells for Autologous TransplantatIon in SubjectS With MM - Mayo Clinic

    A total of 207 subjects will be randomized into the study which will employ a double-blind placebo-controlled setting to assess the efficacy and safety of G-CSF ...

  2. Phase I TH-302 Plus Gemcitabine Plus Nab-Paclitaxel in Pancreatic Cancer - Mayo Clinic

    About this study. This is a multicenter, open-label, Phase 1, dose escalation trial to evaluate the safety, tolerability, and recommended Phase 2 dose ...

  3. Faculty - Cardiovascular Research Center - Mayo Clinic Research

    Mayo Clinic faculty members in pediatrics, pharmacology, physiology, radiology and surgery are among those dedicated to advancing cardiovascular disease ...

  4. A Study to Evaluate Direct Measurement of Proinsulin Clearance in Humans - Mayo Clinic

    The purpose of this study is to determine if changes in fasting glucose and FFA concentrations alter 1st phase insulin secretion and proinsulin secretion in non ...

  5. Head and neck cancers - Doctors and departments - Mayo Clinic

    Learn about innovative treatment for throat cancers, mouth cancers, tongue cancers, tonsil cancers and other cancers that affect the head and neck.

  6. Mobile Educations Effect on Pain Outcomes - Mayo Clinic

    The purpose of this study is to explore the clinical impact of pain management education using a mobile web-based education delivery system compared to standard ...

  7. Ulrich Specks, M.D. - Mayo Clinic Faculty Profiles

    Mayo Clinic researcher Ulrich Specks, M.D., focuses on antineutrophil cytoplasmic antibody (ANCA)-associated vasculitis.

  8. Phase III Open Label Study of MEDI 4736 With/Without Tremelimumab Versus Standard of Care (SOC) in Recurrent/Metastatic Head and Neck Cancer - Mayo Clinic

    Phase III Open Label Study of MEDI 4736 With/Without Tremelimumab Versus Standard of Care (SOC) in Recurrent/Metastatic Head and Neck Cancer · More about ...

  9. Study of TH-302 or Placebo in Combination With Pemetrexed in Patients With Non-squamous Non-small Cell Lung Cancer - Mayo Clinic

    Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and ...

  10. Efficacy and Safety Study of Mepolizumab in Subjects With Severe Hypereosinophilic Syndrome (HES) - Mayo Clinic

    About this study. Mepolizumab is a humanized monoclonal antibody. In conditions where eosinophilia is considered to play an important part in the pathology, ...